SC
XERS icon

Sessa Capital’s Xeris Biopharma Holdings XERS Stock Holding History

Sessa Capital’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,661,237
Closed -$8.97M – 51
2021
Q3 		$8.97M Hold
3,661,237
– – 0.44% 26
2021
Q2 		$14.9M Buy
3,661,237
+243,037
+7% +$927K 0.56% 30
2021
Q1 		$15.4M Sell
3,418,200
-754,259
-18% -$4.07M 0.59% 23
2020
Q4 		$20.5M Hold
4,172,459
– – 1.31% 14
2020
Q3 		$24.7M Hold
4,172,459
– – 2.02% 13
2020
Q2 		$11.1M Buy
4,172,459
+940,000
+29% +$3.27M 1.12% 15
2020
Q1 		$6.3M Buy
+3,232,459
New +$13.9M 0.77% 15

Other funds holding XERS

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Sessa Capital's XERS Position: Q4 2021 in Review

Sessa Capital sold out of Xeris Biopharma Holdings (XERS) in Q4 2021, closing a stake of 3,661,237 shares — an estimated $8.97M sold.

Sessa Capital first reported a position in XERS in Q1 2020 and held it in 7 quarters. The position peaked at $24.7M in Q3 2020. 92 funds tracked by Wall St. Rank hold XERS as of Q4 2021.

  • Sessa Capital reported no remaining Xeris Biopharma Holdings position as of Q4 2021 after selling out during the quarter.
  • Sessa Capital sold 3,661,237 Xeris Biopharma Holdings shares in Q4 2021, an estimated $8.97M.
  • Sessa Capital first reported a position in Xeris Biopharma Holdings in Q1 2020 and held it in 7 quarters.
  • Sessa Capital's Xeris Biopharma Holdings position peaked at $24.7M in Q3 2020.
  • 92 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q4 2021.

Based on Sessa Capital's 13F filing for Q4 2021, filed 14 Feb 2022.